IRBs seeking more money for clinicals
This article was originally published in The Gray Sheet
Executive Summary
Institutional review board fees of $1,500-$2,000 are becoming increasingly prevalent in clinical agreements, according to Thoratec VP-Regulatory Affairs Donald Middlebrook. When budgeting for trials, "I used to set aside...for the few centers [that required] the charges. Now it's almost standard," the exec told IIR's Clinical Trial Strategies for Medical Devices & Diagnostics conference Sept. 30 in Washington, D.C...